C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Evaluation of the levels of the ultrasensitive C-reactive protein (CRPus) in subjects with obstructive sleep apnea- hypopnea syndrome Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 1046-1048 Year: 2012
The impact of obstructive sleep apnoea hypopnoea syndrome (OSAHS) on serum creatine phosphokinase (CK) levels in children Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine Year: 2010